Request for Covid-19 Impact Assessment of this Report
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
The report includes as follows:
The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for RNAi for Therapeutic , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions).
The report provides introduction of leading Global manufacturers.
RNAi for Therapeutic market prospects to 2025 are included (in sales, consumption and price).
Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
Asia-Pacific (China, India, Japan, Southeast Asia etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)
By Type
siRNA
miRNA
shRNA
By End-User / Application
Cancer
Cardiovascular
HBV
Others
By Company
Alnylam Pharmaceuticals
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
miRagen Therapeutics
Gradalis
Sirnaomics
1 Market Definition
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application
2 Global Market by Vendors
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors
3 Global Market by Type
3.1 Market Share
3.2 Introduction of End-Use by Different Products
4 Global Market by End-Use / Application
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs
5 Global Market by Regions
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa
6 North America Market
6.1 by Type
6.2 by End-Use / Application
6.3 by Regions
7 Europe Market
7.1 by Type
7.2 by End-Use / Application
7.3 by Regions
8 Asia-Pacific Market
8.1 by Type
8.2 by End-Use / Application
8.3 by Regions
9 South America Market
9.1 by Type
9.2 by End-Use / Application
9.3 by Regions
10 Middle East & Africa Market
10.1 by Type
10.2 by End-Use / Application
10.3 by Regions
11 Market Forecast
11.1 Global Market Forecast (2020-2025)
11.2 Market Forecast by Regions (2020-2025)
11.3 Market Forecast by Type (2020-2025)
11.4 Market Forecast by End-Use / Application (2020-2025)
12 Key Manufacturers
12.Toshiba Alnylam Pharmaceuticals
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Arrowhead
12.3 Dicerna Pharmaceuticals
12.4 Mirna Therapeutics
12.5 Quark Pharmaceuticals
12.6 RXi Pharmaceuticals
12.7 miRagen Therapeutics
12.8 Gradalis
12.9 Sirnaomics
13 Price Overview
13.1 Price Segment
13.2 Price Trend
14 Research Conclusion
Table Global RNAi for Therapeutic Market and Growth by Type
Table Global RNAi for Therapeutic Market and Growth by End-Use / Application
Table Global RNAi for Therapeutic Revenue (Million USD) by Vendors (2017-2019)
Table Global RNAi for Therapeutic Revenue Share by Vendors (2017-2019)
Table Global RNAi for Therapeutic Market Volume (Volume) by Vendors (2017-2019)
Table Global RNAi for Therapeutic Market Volume Share by Vendors (2017-2019)
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
Table Global RNAi for Therapeutic Market (Million USD) by Type (2017-2019)
Table Global RNAi for Therapeutic Market Share by Type (2017-2019)
Table Global RNAi for Therapeutic Market Volume (Volume) by Type (2017-2019)
Table Global RNAi for Therapeutic Market Volume Share by Type (2017-2019)
Table Global RNAi for Therapeutic Market (Million USD) by End-Use / Application (2017-2019)
Table Global RNAi for Therapeutic Market Share by End-Use / Application (2017-2019)
Table Global RNAi for Therapeutic Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global RNAi for Therapeutic Market Volume Share by End-Use / Application (2017-2019)
Table Global RNAi for Therapeutic Market (Million USD) by Regions (2017-2019)
Table Global RNAi for Therapeutic Market Share by Regions (2017-2019)
Table Global RNAi for Therapeutic Market Volume (Volume) by Regions (2017-2019)
Table Global RNAi for Therapeutic Market Volume Share by Regions (2017-2019)
Table North America RNAi for Therapeutic Market (Million USD) by Type (2017-2019)
Table North America RNAi for Therapeutic Market Share by Type (2017-2019)
Table North America RNAi for Therapeutic Market (Million USD) by End-Use / Application (2017-2019)
Table North America RNAi for Therapeutic Market Share by End-Use / Application (2017-2019)
Table North America RNAi for Therapeutic Market (Million USD) by Regions (2017-2019)
Table North America RNAi for Therapeutic Market Share by Regions (2017-2019)
Table Europe RNAi for Therapeutic Market (Million USD) by Type (2017-2019)
Table Europe RNAi for Therapeutic Market Share by Type (2017-2019)
Table Europe RNAi for Therapeutic Market (Million USD) by End-Use / Application (2017-2019)
Table Europe RNAi for Therapeutic Market Share by End-Use / Application (2017-2019)
Table Europe RNAi for Therapeutic Market (Million USD) by Regions (2017-2019)
Table Europe RNAi for Therapeutic Market Share by Regions (2017-2019)
Table Asia-Pacific RNAi for Therapeutic Market (Million USD) by Type (2017-2019)
Table Asia-Pacific RNAi for Therapeutic Market Share by Type (2017-2019)
Table Asia-Pacific RNAi for Therapeutic Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific RNAi for Therapeutic Market Share by End-Use / Application (2017-2019)
Table Asia-Pacific RNAi for Therapeutic Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific RNAi for Therapeutic Market Share by Regions (2017-2019)
Table South America RNAi for Therapeutic Market (Million USD) by Type (2017-2019)
Table South America RNAi for Therapeutic Market Share by Type (2017-2019)
Table South America RNAi for Therapeutic Market (Million USD) by End-Use / Application (2017-2019)
Table South America RNAi for Therapeutic Market Share by End-Use / Application (2017-2019)
Table South America RNAi for Therapeutic Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa RNAi for Therapeutic Market Share by Regions (2017-2019)
Table Middle East & Africa RNAi for Therapeutic Market (Million USD) by Type (2017-2019)
Table Middle East & Africa RNAi for Therapeutic Market Share by Type (2017-2019)
Table Middle East & Africa RNAi for Therapeutic Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa RNAi for Therapeutic Market Share by End-Use / Application (2017-2019)
Table Middle East & Africa RNAi for Therapeutic Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa RNAi for Therapeutic Market Share by Regions (2017-2019)
Table Global RNAi for Therapeutic Market (Million USD) Forecast by Regions (2020-2025)
Table Global RNAi for Therapeutic Market Share Forecast by Regions (2020-2025)
Table Global RNAi for Therapeutic Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global RNAi for Therapeutic Market Volume Share Forecast by Regions (2020-2025)
Table Global RNAi for Therapeutic Market (Million USD) Forecast by Type (2020-2025)
Table Global RNAi for TherapeuticMarket Share by Forecast Type (2020-2025)
Table Global RNAi for Therapeutic Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global RNAi for Therapeutic Market Share Forecast by End-Use / Application (2020-2025)
Table Sales Revenue, Volume, Price, Cost and Margin of Alnylam Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Arrowhead
Table Sales Revenue, Volume, Price, Cost and Margin of Dicerna Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Mirna Therapeutics
Table Sales Revenue, Volume, Price, Cost and Margin of Quark Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of RXi Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of miRagen Therapeutics
Table Sales Revenue, Volume, Price, Cost and Margin of Gradalis
Table Sales Revenue, Volume, Price, Cost and Margin of Sirnaomics
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...